Table 1.
Chemical probe | HTS assay | Cells (condition) | Library | Mode of action | Parameters of RO5 | Structure | References |
---|---|---|---|---|---|---|---|
IWR‐1 | Luciferase reporter (SuperTOPFlash) | Mouse L cells (Wnt3a‐CM) | 198 080 (UTSouthwestern chemical library) | Tankyrase inhibition |
MWT = 409.45 CLog P = 2.522 H‐bond donors = 1 H‐bond acceptors = 4 |
33 | |
XAV939 | Luciferase reporter (SuperTOPFlash) | HEK293 | N/A | Tankyrase inhibition |
MWT = 312.31 CLog P = 3.82964 H‐bond donors = 1 H‐bond acceptors = 3 |
34 | |
JW74 | Fluorescence imaging (SuperTOP‐d1EGFP) | HEK293 (Wnt3a‐CM) | 37 000 | Tankyrase inhibition |
MWT = 456.52 CLog P = 4.05445 H‐bond donors = 0 H‐bond acceptors = 6 |
30 | |
WIKI4 | Luciferase reporter (BAR, TCF reporter) | A375 (Wnt3a‐CM) | 6492 (KINASet library, Chembridge) | Tankyrase inhibition |
MWT = 521.60 CLog P = 5.21344 H‐bond donors = 0 H‐bond acceptors = 6 |
35 | |
K‐756 | Luciferase reporter (TCF reporter) | DLD‐1 | N/A | Tankyrase inhibition |
MWT = 433.51 CLog P = 3.4062 H‐bond donors = 1 H‐bond acceptors = 5 |
36 | |
IWP‐2 | Luciferase reporter (SuperTOPFlash) | Mouse L cells (Wnt3a‐CM) | 198 080 (UTSouthwestern chemical library) | Porcupine inhibition |
MWT = 466.59 CLog P = 4.94517 H‐bond donors = 1 H‐bond acceptors = 4 |
33 | |
LGK974 | Luciferase reporter (SuperTOPFlash) | TM3 cells (co‐cultured with L‐cell Wnt3A) | ~2 400 000 | Porcupine inhibition |
MWT = 396.45 CLog P = 1.77295 H‐bond donors = 1 H‐bond acceptors = 6 |
38 | |
Pyrvinium pamoate | Luciferase reporter (β‐catenin‐Fluc/Axin‐RLuc fusion proteins) | Xenopus egg extracts (LRP6ICD) | FDA‐approved drug library etc | Activation of CK1α |
MWT = 382.53 CLog P = 2.78575 H‐bond donors = 0 H‐bond acceptors = 0 |
41 | |
ICG‐001 | Luciferase reporter (TOPFlash) | SW480 | 5000 | Inhibition of β‐catenin‐CBP interaction |
MWT = 548.64 CLog P = 6.13165 H‐bond donors = 2 H‐bond acceptors = 4 |
54 | |
PKF115‐584 | ELISA (β‐catenin/ GST‐TCF4 recombinant proteins) | N/A | 7000 (natural compounds library) | Inhibition of β‐catenin‐TCF interaction |
MWT = 790.77 CLog P = 6.87757 H‐bond donors = 3 H‐bond acceptors = 11 |
44 | |
iCRT14 | Luciferase reporter (TCF reporter) | Drosophila Cl8 cells (dAxin‐dsRNA) | 14 977 (ICCB‐Longwood collection, Harvard) | Inhibition of β‐catenin‐TCF interaction |
MWT = 375.45 CLog P = 5.70349 H‐bond donors = 0 H‐bond acceptors = 3 |
26 | |
NC043 | Luciferase reporter (TOPFlash) |
HEK293T (Wnt1 overexpression, Wnt3a‐CM, or LiCl) |
4000 | Indirect inhibition of β‐catenin‐TCF interaction |
MWT = 330.42 CLog P = 1.2362 H‐bond donors = 1 H‐bond acceptors = 3 |
48 | |
Niclosamide | Luciferase reporter (S1004A4 promoter reporter) | HCT116 | 1280 (LOPAC Sigma‐Aldrich) | Inhibition of formation of β‐catenin/TCF complex |
MWT = 327.12 CLog P = 4.34465 H‐bond donors = 2 H‐bond acceptors = 2 |
47 | |
ZINC02092166 | Fluorescence polarization and AlphaScreen assays (β‐catenin/fluorescein‐TCF4 recombinant proteins) | N/A | 2093 (Sigma‐Aldrich, Pfizer, NCI etc) | Inhibition of β‐catenin‐TCF interaction |
MWT = 349.27 CLog P = 3.91846 H‐bond donors = 2 H‐bond acceptors = 8 |
45 | |
LF3 | AlphaScreen assay (GST‐β‐catenin/His‐TCF4 recombinant proteins) | N/A | 16 671 (WDI compounds, ChemBioNet) | Inhibition of β‐catenin‐TCF interaction |
MWT = 416.56 CLog P = 2.582 H‐bond donors = 2 H‐bond acceptors = 4 |
46 | |
Hexachlorophene | Luciferase reporter (TOPFlash) | HEK293 expressing hFz‐1 (Wnt3a‐CM) | 960 (Genesis Plus Collection, MicroSource Discovery) | β‐Catenin degradation through SIAH‐1 induction |
MWT = 406.89 CLog P = 7.02708 H‐bond donors = 2 H‐bond acceptors = 2 |
56 | |
Axitinib | Luciferase reporter (SuperTOPFlash) | HEK293FT (GSK‐3 inhibitor, 6BIO) | 460 (FDA‐approved drug library) | β‐Catenin degradation through SHPRH stabilization |
MWT = 386.47 CLog P = 3.3269 H‐bond donors = 3 H‐bond acceptors = 4 |
58 | |
CGK062 | Luciferase reporter (TOPFlash) | HEK293 expressing hFz‐1 (Wnt3a‐CM) | 800 | β‐Catenin degradation through PKCα activation |
MWT = 408.41 CLog P = 3.75537 H‐bond donors = 2 H‐bond acceptors = 5 |
59 | |
SEN461 | Luciferase reporter (TCF reporter) | DBTRG.05MG | 16 000 (Siena Biotech internal compounds collection) | β‐Catenin degradation through Axin stabilization |
MWT = 486.57 CLog P = 2.0554 H‐bond donors = 0 H‐bond acceptors = 6 |
60 | |
CCT031374 | Luciferase reporter (TCF reporter) | HEK293 expressing Dvl2‐ER (Disheveled‐estrogen receptor fusion) | 63 040 (The Cancer Research UK Center for Cancer Therapeutics compound library) | β‐Catenin degradation + unknown mechanism |
MWT = 353.43 CLog P = 4.5174 H‐bond donors = 0 H‐bond acceptors = 2 |
25 | |
MSAB | Luciferase reporter (TOPFlash) | HCT116 | 22 000 (Chembridge and Broad Institute) | β‐Catenin binding and degradation |
MWT = 305.35 CLog P = 3.405 H‐bond donors = 1 H‐bond acceptors = 3 |
61 | |
KY1220 | Luciferase reporter (TOPFlash) | HEK293 (Wnt3a‐CM) | ~3599 (Chemdiv and Sigma LOPAC 1280) | Axin binding and β‐catenin degradation |
MWT = 314.32 CLog P = 1.60552 H‐bond donors = 2 H‐bond acceptors = 2 |
62 | |
FH535 | SEAP reporter (TOPFlash) | HepG2 | 11 600 (DIVERSet collection, ChemBridge) | Repression of β‐catenin recruitment |
MWT = 361.19 CLog P = 3.95088 H‐bond donors = 1 H‐bond acceptors = 2 |
29 | |
GGTI‐286 | Eye phenotype | Zebrafish embryos (GSK‐3 inhibitor, 6BIO) | 282 (SCADS inhibitor kit) | Inhibition of nuclear accumulation of β‐catenin |
MWT = 429.58 CLog P = 3.4042 H‐bond donors = 3 H‐bond acceptors = 3 |
63 | |
Brefeldin A | Luciferase reporter (TOPFlash and HAL promoter reporter) | HepG2 | 361 (SCADS inhibitor kit) | Repression of β‐catenin mRNA |
MWT = 280.36 CLog P = .538999 H‐bond donors = 2 H‐bond acceptors = 3 |
23 |
Chemical structures were drawn using ChemDraw. The molecular weights (MWT), calculated octanol/water partition coefficient (CLog P) values, and number of hydrogen bond donors and acceptors were calculated using ChemDraw or Molecular Operating Environment (MOE).
BAR, β‐catenin‐activated reporter; CBP, CREB‐binding protein; CK1α, casein kinase‐1α; GSK‐3, glycogen synthase kinase‐3; N/A, not available; PKCα, protein kinase Cα; SCADS, Screening Committee of Anticancer Drugs; SEAP, secreted alkaline phosphate; TCF, T‐cell factor.